Plymouth Pharmaceuticals, Inc. and its division, Loma Lux Laboratories, is dedicated to promoting worldwide health and wholeness. Our focus is the discovery, research, and development of natural, low dose, low side effect treatments that bring freedom from chronic diseases through correction of basic underlying disease mechanisms. Responsible manufacturing practices, integrity of our advertisements, and prompt, efficient service are central to our corporate philosophy. Furthermore, it is our mission to make these treatments widely and easily available to those who need them.

Plymouth Pharmaceuticals. was incorporated in 1991 under the direction of Steven A. Smith, M.D. (see bio below), a dermatologist, and launched its first RX product, Psorizide® Ultra, in the mid 1990’s to treat psoriasis, eczema, and seborrhea. Psorizide® Ultra was then reformulated for the treatment of psoriasis specifically and became Psorizide® Forte in 2001; at that time Psorizide® Ultra’s indication became solely the treatment of eczema and seborrhea. Eczemol® for the treatment of moderate to severe eczema, and Acunol™, for the treatment of mild to moderate acne were launched in 2006. Plymouth Pharmaceuticals™ currently also distributes a line of OTC products for various conditions under the dba Loma Lux® Laboratories; these products have distribution in Target nationwide.


Dr. Smith received his BA in 1975 from Indiana Wesleyan University (Marion, Indiana) and his MD in 1979 from Indiana University School of Medicine (Indianapolis, Indiana). Dr. Smith completed an Internal Medicine Internship in 1980, an Internal Medicine Residency in 1982, and a Dermatology Residency in 1984, all at the University of Texas Health Science Center (San Antonio, TX).

Steven A. Smith, MD

Dr. Smith is a board certified dermatologist (American Board of Dermatology, 1985) and a board certified internist (American Board of Internal Medicine, 1982).

Dr. Smith is a Fellow of the American College of Physicians, American Academy of Dermatology, and American Society of Dermatological Surgery. He is a member of Alpha Omega Alpha Medical Honor Society, American Medical Association, Oklahoma State Medical Association, Oklahoma State Dermatological Society, Tulsa County Medical Society, Tulsa Dermatological Society, International Society of Dermatology, and International Society of Dermatological Surgery. In addition, he received the Outstanding Achievement Award in Science and Health from Indiana Wesleyan University in 1993.

Dr. Smith currently serves as Clinical Associate Professor of Dermatology at the University of Oklahoma College of Medicine in Tulsa, Oklahoma. Dr. Smith also currently serves as active staff at St. John's Medical Center, Hillcrest Medical Center St. Francis Hospital and Tulsa Regional, all in Tulsa, Oklahoma. Board of Directors, Tulsa County Medical Society, 2003

Previously, Dr. Smith served as President of the Oklahoma State Dermatological Society (1988-1989), Assistant Professor of Dermatology at Oral Roberts University School of Medicine, Tulsa, Oklahoma (1985-1988), Assistant Instructor of Dermatology at the University of Texas Health Science Center, San Antonio, Texas (1983-1984), and Secretary/Treasurer of the Oklahoma State Dermatological Society (1986-1987).

 
     
TERMS & CONDITIONS ¤ PRIVACY POLICY
©2006 PLYMOUTH PHARMACEUTICALS™. ALL RIGHTS RESERVED.
 
Click Here for info on Psorizide® Forte Click Here for info on ECZEMOL® Click Here for info on ACUNOL™